论文部分内容阅读
2型糖尿病(T2DM)是心血管疾病危险因素之一,其发病率在全世界正在以传染病的速度增加。如今,性腺机能减退症和勃起功能障碍(ED)被认为是T2DM的并发症。近来证据表明,糖尿病人群中,ED是隐性冠心病的明显预兆。T2DM患者由于性腺机能减退导致性生活减弱。T2DM患者睾酮水平低下的程度与伴发ED的严重程度、性欲低下和性生活次数减少程度明显相关。睾酮替换疗法(TRT)能提高性腺机能减退症患者的性功能。另外TRT可以改善肥胖、胰岛素抗性和胆固醇总量。但是有关TRT对T2DM患者影响
Type 2 diabetes mellitus (T2DM) is one of the risk factors for cardiovascular disease, and its incidence is increasing worldwide at an infectious disease rate. Hypogonadism and erectile dysfunction (ED) are now considered as complications of T2DM. Recent evidence suggests that ED is a clear sign of recessive coronary heart disease in people with diabetes. T2DM patients due to hypogonadism lead to decreased sexual life. The low level of testosterone in T2DM patients was significantly associated with the severity of concomitant ED, hypoactive sexual desire and the reduction in sexual activity. Testosterone replacement therapy (TRT) can improve sexual function in patients with hypogonadism. In addition TRT can improve obesity, insulin resistance and total cholesterol. However, the impact of TRT on T2DM patients